The third inoculation of the new coronavirus vaccine is scheduled to begin next month.

An expert group of the Ministry of Health, Labor and Welfare has approved the use of Pfizer's vaccine, and it is expected that the target of inoculation will be 18 years old or older.

In addition, the policy that the third inoculation will be carried out by occupational inoculation has been decided, and it is expected to start by March next year.

We have compiled the latest information, including the side reactions of the third inoculation that you are interested in.

■ To Pfizer vaccine approval approval Target is 18 years old or older

For the third time of vaccination the Ministry of Health, Labor and Welfare is a policy to target only people generally 8 months or more were inoculated twice

▽ health care workers from next month

▽ elderly from January next year

will begin vaccination.

The expert group on the night of the 10th approved the approval of Pfizer's vaccine for the third inoculation, and the Ministry of Health, Labor and Welfare is expected to officially approve it soon.

On the other hand, due to lack of efficacy and safety data for children under the age of 18, it is expected that the target will be raised from 12 years old or older to 18 years old or older at the time of starting inoculation. ..

It is expected that some people under the age of 18 will be eligible for the third vaccination as early as February next year, and the Ministry of Health, Labor and Welfare plans to consider lowering the target age as soon as additional data is submitted by Pfizer.

<Vaccine reaction> "Similar to the second inoculation"

According to announcements by Pfizer and others, in clinical trials conducted overseas, the side reactions after the third inoculation were about the same as up to the second.

▽ It

is the result of analyzing the symptoms within 7 days from

the inoculation

of 2682 people aged 16 to 55 years

who received the second inoculation and 289 people aged 18 to 55 years who received the third inoculation


▽ Malaise is 61.5% for the second time, 63.7% for the third time

▽ Headache is 54% for the second time, 48.4% for the third time

▽ Myalgia is 39.3% for the second time, 39.1% for the third time

▽ Fever of 38 degrees or more The second time was

confirmed by

16.4%, and the third time was

confirmed by



<Expert> "It is important to proceed with the third wave, which is likely to be the sixth wave."

Regarding the third inoculation, Tetsuo Nakayama, a specially appointed professor at Kitasato University, said, "It is often unknown how long the effect will last not only with the new corona but also with other vaccines, but the effect of the conventional vaccines has been declining on a yearly basis. When the antibody level drops, some people become infected and become more severe. Currently, the number of infected people is decreasing, but there is a high possibility that the epidemic "6th wave" will occur, and it is easy for elderly people to become severely ill. It is important to promote the third vaccine to people and medical personnel. I think it will be an important option for advancing infection control. "

Regarding the side reaction of the third inoculation and the different vaccine from the second one, "I think that if you take the same company's vaccine twice, you should give the same vaccine the third time, but the same" Messenger RNA " If it is a vaccine, there is no big difference in the effect and side reactions, so I don't think there is a big difference even if different vaccines are given. There are multiple vaccines from overseas, so you don't have to worry too much about it. "

■ Occupational inoculation will be implemented by March next year

It is about occupational inoculation performed in companies and universities.

Initially, the government was considering giving the third vaccination to the local government in principle, but decided to do it for occupational vaccination as well.

If the conditions are met, we are adjusting to start the third inoculation by March next year, eight months after the start of occupational inoculation.

The policy is to use the modelna vaccine for inoculation, and if an application for approval is submitted for the third inoculation, it will be examined promptly.

According to the Ministry of Health, Labor and Welfare, more than 9.42 million people (9.423,708 people) have completed two vaccinations in the workplace by the 7th of this month.

<Company> Prepare for inoculation

A major insurance company headquartered in Marunouchi, Tokyo, has decided to make concrete preparations for the third inoculation in the workplace.

This company provided the first and second occupational inoculations to approximately 12,000 employees working in the three prefectures of the Tokyo metropolitan area from June to September.

As for the third inoculation, we plan to inoculate about 700 people a day at two venues, including the Marunouchi head office building.

When the government indicates the specific details of the third inoculation in the workplace, such as the timing and conditions of inoculation, we plan to proceed with specific preparations such as making reservations for the venue.

Kaoru Asano, General Manager of Meiji Yasuda Life, said, "From the viewpoint of having many points of contact with customers, convenience of employees, and ensuring safety, occupational inoculation has great merits for the company, so if the third time is possible, we will respond promptly. I want you to show the schedule as soon as possible so that you can prepare for the venue. "

■ Overview of new corona measures Government draft

Then, Prime Minister Kishida expressed his thoughts on the 12th regarding the overall picture of measures to prepare for the next spread of infection, and the draft was revealed.

1. Vaccination


▽ including additional third vaccination from next month, with more than approximately 8 months after receiving the vaccination of 2 times to make hope everyone out of the only subjects can be vaccinated

for ▽ occupational vaccination Will start the third vaccination by March next year if almost all of the people who received the second vaccination are recognized as eligible.

We will support the development cost of up to about 2 billion yen per therapeutic drug for the development of therapeutic drugs, and aim to put the oral drug for mildly ill patients into practical use by the end of the year.

2. Medical provision system

To strengthen the medical care provision system

▽ After

building a system that allows 30% more patients to be hospitalized within this month than this summer

▽ From next month onward, the status of bed securing and usage rate for each medical institution will be announced every month. It is said that it will be thoroughly "visualized".

3. Inspection / vaccination certificate

▽ For those who cannot receive vaccination due to health reasons, we will make it possible to receive free PCR tests without reservation until March next year.

▽ If the infection is spreading, the prefecture At the discretion of, even if you are asymptomatic, you will be able to receive the test for free.

In addition, there is a policy to digitize the vaccination certificate by the end of the year and make it available in Japan.

The government will open a countermeasures headquarters on the 12th to compile an overall picture of the new corona countermeasures that incorporates these details.

■ “1st and 2nd inoculations for 5 to 11 years old” Pfizer applies for approval

On the other hand, on the 10th, there was a movement in the age group that had not been vaccinated so far.

Pfizer has applied to the Ministry of Health, Labor and Welfare to expand the scope of the new coronavirus vaccine from 12 years old and over to 5 years old and over.

According to Pfizer and others, they applied for approval from the Ministry of Health, Labor and Welfare to include the first and second vaccinations for 5 to 11 years old.

Other vaccines approved in Japan are targeted for ages

▽ Moderna is 12 years old and over

▽ AstraZeneca is 18 years old and over, and this

is the first time that an application for approval has been made for those under 12 years old.

Based on the data of overseas clinical trials submitted by Pfizer, the Ministry of Health, Labor and Welfare will examine the efficacy and safety before deciding whether or not to approve it.

Last month, the US FDA (Food and Drug Administration) changed the target of emergency use permission for Pfizer vaccines, which had been 12 years old or older, and added children aged 5 to 11 years.